Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next three days.
In the meantime, you can enjoy access to all the latest news, events and resources for different therapy areas on our website.
-
Asthma Control Test
The online Asthma Control Test (ACT)
A validated patient-based tool to assess asthma control
Developed by medical asthma experts and validated on asthma patients, the ACT is a 5-question test to evaluate how asthma is affecting your patient’s quality of life. In just minutes, you’ll have a useful score to help determine their level of asthma control and the level of treatment needed. 2
-
GINA Guide
The GINA Guide
Essential information in a convenient fold-out pocket card
The 2019 GINA asthma management and prevention guide recognises the need for partnership between the patient and HCP, emphasising good communication and shared decision-making. 3
Relvar Ellipta is indicated for the maintenance treatment of asthma.
Dosage:
The recommended dose of Relvar Ellipta is:
One inhalation of Relvar Ellipta 100/25 micrograms once daily or
One inhalation of Relvar Ellipta 200/25 micrograms once daily
Safety Information:
Contraindications: Relvar Ellipta is contraindicated in patients with severe milk-protein allergy or who have demonstrated hypersensitivity to either fluticasone furoate, vilanterol or any of the excipients.
Warnings and Precautions:
Exacerbations:
Relvar Ellipta should not be used to treat acute asthma symptoms or an acute exacerbation in COPD, for which a short-acting bronchodilator is required. Increasing use of short-acting bronchodilators to relieve symptoms indicates deterioration of control and patients should be reviewed by a physician.
Adverse Reactions: Very common: Headache, Nasopharyngitis.
References:
- Ställberg B et al. Respir Med 2003;97:835–843.
- The Asthma Control Test. Available at: http://www.asthmacontroltest.com/ (last accessed October 2018).
- 2019 GINA Report.
- Local Relvar Prescribing Information based on GDS 10.
Relvar Ellipta was developed in collaboration with INNOVIVA
Trade marks are owned by or licensed to the GSK group of companies.
©2021 GSK group of companies or its licensor.
